Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Dragalin

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Biopharmaceutical Statistics|April 20, 2025
Joint modeling of longitudinal endpoints and its applications to trial planning, monitoring and analysisLiangcai Zhang, George Capuano, Vladimir Dragalin, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Viewpoints on the FDA draft adaptive designs guidance from the PhRMA working groupPaul Gallo, Keaven Anderson, Christy Chuang-Stein, et al.
Journal of Biopharmaceutical Statistics|January 24, 2025
Bayesian efficient safety monitoring: a simple and well-performing framework to continuous safety monitoring of adverse events in randomized clinical trialsLiangcai Zhang, Ming Chen, Vladimir Dragalin, et al.
Innovations in Clinical Neuroscience|August 24, 2011
How Adaptive Trial Designs can Increase Efficiency in Psychiatric Drug Development: A Case StudyJoan Shen, Sheldon Preskorn, Vladimir Dragalin, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshopMichael Krams, Carl-Fredrik Burman, Vladimir Dragalin, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive TrialsZoran Antonijevic, Paul Gallo, Christy Chuang-Stein, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Biopharmaceutical Statistics|April 20, 2025
Joint modeling of longitudinal endpoints and its applications to trial planning, monitoring and analysisLiangcai Zhang, George Capuano, Vladimir Dragalin, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Viewpoints on the FDA draft adaptive designs guidance from the PhRMA working groupPaul Gallo, Keaven Anderson, Christy Chuang-Stein, et al.
Journal of Biopharmaceutical Statistics|January 24, 2025
Bayesian efficient safety monitoring: a simple and well-performing framework to continuous safety monitoring of adverse events in randomized clinical trialsLiangcai Zhang, Ming Chen, Vladimir Dragalin, et al.
Innovations in Clinical Neuroscience|August 24, 2011
How Adaptive Trial Designs can Increase Efficiency in Psychiatric Drug Development: A Case StudyJoan Shen, Sheldon Preskorn, Vladimir Dragalin, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshopMichael Krams, Carl-Fredrik Burman, Vladimir Dragalin, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive TrialsZoran Antonijevic, Paul Gallo, Christy Chuang-Stein, et al.
Pageof 3